Skip to main content

ÍS
EN

Forsíða

Forsíða

Þorvarður Jón Löve - Professor

Þorvarður Jón Löve

–

School of Health Sciences

Þorvarður Jón Löve

Professor

Location
Sturlugata 8
Email
thl [at] hi.is

Unit
Faculty of Medicine

Published works

2024

Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European CountriesArthritis Care and Research
Prescription of non-steroidal anti-inflammatory drugs for patients with inflammatory arthritis decreases with the initiation of tumour necrosis factor inhibitor therapyScandinavian Journal of Rheumatology
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined SignificanceAnnals of Internal Medicine
Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitorsScandinavian Journal of Rheumatology
Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatmentJoint Bone Spine
Prior cancer and risk of monoclonal gammopathy of undetermined significanceHaematologica
Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in IcelandInternational Journal of Drug Policy
Patient-reported outcomes and PRO remission rates in 12,262 biologic-naïve patients with psoriatic arthritis treated with TNF-inhibitors in routine careThe Journal of rheumatology
Deciphering the genetics and mechanisms of predisposition to multiple myelomaNature Communications
Population-based screening cohort study reveals no association between monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), multiple myeloma (MM), and alopeciaArchives of dermatological research

2023

Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF-inhibitorRheumatology (Oxford, England)
Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaborationArthritis Research and Therapy
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritisAnnals of the Rheumatic Diseases
Comment onRheumatology (United Kingdom)
Trends of perceived disruption in healthcare services during the pandemic: findings from the COVID-19 National Resilience Cohort in IcelandEuropean Journal of Public Health
Trends of perceived disruption in healthcare services during the pandemicEuropean Journal of Public Health
Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogenRheumatology (Oxford, England)
CorrectionBlood Cancer Journal
Author Correction: Prevalence of smoldering multiple myeloma based on nationwide screeningNature Medicine
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometryBlood Cancer Journal
Management of Nail Disease in Patients With Psoriatic ArthritisThe Journal of rheumatology
Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in psoriatic arthritis; results from the EuroSpA Research Collaboration NetworkArthritis & rheumatology (Hoboken, N.J.)
Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohortsHaematologica
Prevalence of smoldering multiple myeloma based on nationwide screeningNature Medicine
Physical and cognitive impact following SARS-CoV-2 infection in a large population-based case-control studyCommunications medicine
Immunophenotypic assessment of clonal plasma cells and B-cells in bone marrow and blood in the diagnostic classification of early stage monoclonal gammopathiesBlood Cancer Journal
Long COVID in Icelandic ChildrenThe Pediatric infectious disease journal

2022

Symptoms, physical measures and cognitive tests after SARS-CoV-2 infection in a large population-based case-control study
High Rate of Hepatitis C Virus Reinfection Among Recently Injecting Drug Users:Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Risk Factors for Diagnosis of Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis, and Ankylosing SpondylitisJournal of Rheumatology
SARS-CoV-2 Infections in Icelandic ChildrenPediatric Infectious Disease Journal
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European CountriesArthritis Care and Research
Does biologic therapy impact the development of PsA among patients with psoriasis?Annals of the Rheumatic Diseases
Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined SignificanceFrontiers in Immunology
Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) MeetingThe Journal of rheumatology
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitorsRMD Open
A patients’ perspective towards the injection devices for Humira® and Imraldi® in a Nationwide witching programFrontiers in Medicine
The first wave of COVID-19 and concurrent social restrictions were not associated with a negative impact on mental health and psychiatric well-beingJournal of Internal Medicine
Defining new reference intervals for serum free light chains in individuals with chronic kidney diseaseBlood Cancer Journal
Body surface area affected by psoriasis and the risk for psoriatic arthritisRheumatology (United Kingdom)
A Patients' Perspective Towards the Injection Devices for Humira® and Imraldi® in a Nationwide Switching ProgramFrontiers in Medicine
Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogenRheumatology

2021

Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexateAnnals of the Rheumatic Diseases
Iceland screens, treats, or prevents multiple myeloma (iStopMM)Blood Cancer Journal
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritisRheumatology (Oxford, England)
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significanceEuropean Journal of Haematology
Outpatient Use of Antimicrobials in Patients With Rheumatoid Arthritis Before and After Treatment With Tumor Necrosis Factor Inhibitors: A Nationwide Retrospective Cohort StudyACR Open Rheumatology
Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in IcelandThe Lancet Gastroenterology and Hepatology
No One Will be Safe until Our Children are SafePediatric Infectious Disease Journal
Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort studyRheumatology (Oxford, England)
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologicsRheumatology (United Kingdom)
Monoclonal gammopathy of undetermined significance and COVID-19Blood Cancer Journal
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) MeetingThe Journal of rheumatology. Supplement
Cascade of care in the Treatment as Prevention for Hepatitis C programme in Iceland
Illness severity and risk of mental morbidities among patients recovering from COVID-19BMJ Open
Validity of chronic disease diagnoses in Icelandic healthcare registriesScandinavian Journal of Public Health
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaborationAnnals of the Rheumatic Diseases

2020

Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritisRheumatology (United Kingdom)
FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid diseaseNature
Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment - Results from 12 countries in EuroSpARheumatology (United Kingdom)

2019

Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligibleRMD Open

2018

Infections and the risk of psoriatic arthritis among psoriasis patientsRheumatology International
„Það er fróðlegt og krefjandi að vinna í teymi“ Þverfræðilegt nám á heilbrigðisvísindas við iHáskóla Íslands: þriggja ára þróunarverkefniTímarit hjúkrunarfræðinga
Treatment as Prevention for Hepatitis C (TraP Hep C) – a nationwide elimination programme in Iceland using direct-acting antiviral agentsJournal of Internal Medicine
Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritisEuropean Heart Journal
Golimumab in the treatment of psoriatic arthritisExpert Review of Clinical Immunology
The majority of patients with psoriatic arthritis are not eligible for randomised clinical trialsClinical and Experimental Rheumatology
Treatment as Prevention for Hepatitis C (TraP Hep C) – a nationwide elimination programme in Iceland using direct-acting antiviral agentsJournal of Internal Medicine

2017

The risk of fracture among patients with psoriatic arthritis and psoriasisAnnals of the Rheumatic Diseases
Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasisAnnals of the Rheumatic Diseases
Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritisRheumatology (United Kingdom)

2016

Bloodstream infections in patients with chronic lymphocytic leukemiaAnnals of Hematology
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic ArthritisArthritis and Rheumatology
The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritisRheumatology (United Kingdom)

2015

Er þörf á sérstakri heilbrigðismóttöku fyrir háskólanemendur?Tímarit hjúkrunarfræðinga
Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritisAnnals of the Rheumatic Diseases

2014

Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasisAnnals of the Rheumatic Diseases
Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement networkPharmacoepidemiology and Drug Safety
Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritisRheumatology (United Kingdom)
Treatments for nail psoriasisJournal of Rheumatology
Vísindastarf á Landspítala – samanburður við Norðurlönd og sóknarfæriLæknablaðið
Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritisAnnals of Internal Medicine

2013

Prevalence and treatment patterns of psoriatic arthritis in the UKRheumatology (United Kingdom)

2012

Borrelia and subsequent risk of solid tumors and hematologic malignancies in SwedenInternational Journal of Cancer
Obesity and the risk of psoriatic arthritisAnnals of the Rheumatic Diseases
Psoriatic arthritis and onycholysis - Results from the cross-sectional reykjavik psoriatic arthritis studyJournal of Rheumatology
ReInternational Journal of Cancer

2011

Validation of Psoriatic Arthritis Diagnoses in Electronic Medical Records Using Natural Language ProcessingSeminars in Arthritis and Rheumatism
Prevalence of the metabolic syndrome in psoriasisArchives of Dermatology

2010

Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasisAnnals of the Rheumatic Diseases
Laboratory tests in autoimmune disease.
Small joint involvement in psoriatic arthritis is associated with onycholysisScandinavian Journal of Rheumatology
Update on Abatacept Therapy of RA.

2009

A 'pilot' study on air-travel and venous thromboembolismBritish Journal of Haematology
A strong heritability of psoriatic arthritis over four generations--the Reykjavik Psoriatic Arthritis Study.Rheumatology (Oxford, England)
Promotion and Regulation of Autoimmune Inflammation by B Cells.

2008

The relationship between cancer and rheumatoid arthritisArthritis Research and Therapy

2007

Psoriatic arthritis in Reykjavik, IcelandJournal of Rheumatology

2004

Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8 ⁺ T cellsClinical and Experimental Immunology

Keywords for Specialisation:

Psoriatic arthritis

Database research